Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Sep 2006 07:30

London Asia Chinese Private Equity06 September 2006 6 September 2006 London Asia Chinese Private Equity Fund Limited ("LACPEF" or "the Fund") Investee Companies Trading On PLUS LACPEF, the China focused investment fund, is pleased to announce that two moreof its investee companies are to begin trading on the UK's PLUS Markets StockMarket. China New Energy Ltd ("CNE") is expected to begin trading today at 525p a share,giving it a market capitalisation of £35 million. Its core business is thesupply of turnkey technology solutions for the production of ethanol, ediblealcohol and acetic acid from a range of bio-resources, including corn,sugarcane, cassava and other bio-resources. As part of the listing process, theFund has invested a further £0.35 million, bringing its total investment in CNEto date to £2.2 million for a 25% stake. CNE is seeking a listing to enable itto tap into the international market for its product, with sales currentlyfocused on the Chinese market. China Biofoods Ltd ("Biofoods") is expected to begin trading on Thursday 7September at 175p a share, giving it a market capitalisation of £12.5 million.The Fund took a 31% stake in June at a cost of £2.1 million. Biofoodsspecialises in the production of highly purified herb extract products, whichare then used to produce traditional Chinese medicine, and as ingredients infunctional foods. China Biofoods reported revenues of £2.9m with profit aftertax of £1.2m for the year ended 31 December 2005. It is listing on PLUS as away of tapping into the international market for its products. Simon Littlewood, Executive Director of LACPEF, commented: "These listings onPLUS follow the successful listing of our investee company Dalian BusinessInstitute in May, with Dalian currently trading at a market capitalisation ofover £18 million, valuing the Fund's stake at £3.6 million against an investmentcost of £2.0 million. The listings demonstrate the value in our investmentportfolio. CNE is listing as it will need considerable amounts of capital goingforward as it seeks to take advantage of its leading position in the ethanolsector in China, where as a result of recent changes in legislation there hasbeen a rapid expansion in the size of the market, as well as taking advantage ofopportunities outside China, with ethanol being looked at worldwide as apotential alternative to highly priced oil. Biofoods is expanding its productrange, and looking to tie up with international partners to sell its productsoverseas." For further information please visit www.londonasiafunds.com or contact: John West/Matt Ridsdale Simon Littlewood Hugh FieldTavistock Communications London Asia Capital plc Collins Stewart LimitedTel: 020 7920 3150 Tel 020 7355 7928 Tel: 020 7523 8000 About China New Energy CNE has established itself as the leading brand in China, with an estimated 60%share of the market for ethanol production equipment in China. The Company'ssuccessful track record is key to growing the business and its technology hasbeen used in over 30 projects. CNE is supported by strong drivers with thedemand for ethanol, a fuel seen as an alternative to oil, growing rapidly andsupported by a recent change in legislation in China requiring 10% of allvehicle oil consumption to be biofuel in 11 of China's Provinces. Similarlegislation is coming into force in many countries, such as the US and EU,creating a potential market for CNE to export its products going forward. For additional information, visit the Company's web site atwww.chinanewenergygroup.com About China Biofoods Biofoods is based in Xuchang, Henan Province, the centre for farming traditionalChinese medical herbs. It specialises in the production of highly purified herbextract products, which are then used to produce traditional Chinese medicine,and as ingredients in functional foods. The market for "Functional Foods" is expanding rapidly worldwide, especially inChina. "Functional Foods" are foods or dietary components that may provide ahealth benefit beyond their basic nutritional value. Such products are aimed ata wide variety of markets, from those with poor diets and limited resourcesseeking additional nutritional content in their diet, to those whose lifestylesand levels of stress require them to eat more healthy food, to the aged who areseeking traditional cures to age related ailments. Biofoods' core products are highly purified linolenic acids, Reshi mushroomspore oil, and deodorized garlic oil. Linolenic acid, also known as Vitamin F,is an essential fatty acid which is not produced by the body, and has been usedto improve hair and skin, reduce blood pressure, help prevent arthritis, lowercholesterol and triglycerides, and reduce the risk of blood clots. Reshimushroom spore oil is broadly used in the health food industry as a supplementand intermediate ingredient. For additional information, please visit the company's web pagewww.chinabiofoods.com.cn This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.